Bio-Rad Laboratories Other Current Liabilities

As of the most recent data (September 2026), BIO.B shows a other current liabilities of $360M. That compares with $310M in the prior-year period — up 14.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIO.B's other current liabilities is now $360M (was $310M) — a 14.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Rad Laboratories is outperforming or lagging.

Tracking BIO.B's other current liabilities over time shows whether Bio-Rad Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $360M That compares with $310M in the prior-year period — up 14.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Bio-Rad Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $360M) with ownership activity and broader fundamentals.

Bio-Rad Laboratories's other current liabilities is $360M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.